Potent Inhibitors of the Plasmodium falciparum Enzymes Plasmepsin I and II Devoid of Cathepsin D Inhibitory Activity
- 9 December 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (1) , 110-122
- https://doi.org/10.1021/jm030933g
Abstract
The hemoglobin-degrading aspartic proteases plasmepsin I (Plm I) and plasmepsin II (Plm II) of the malaria parasite Plasmodium falciparum have lately emerged as putative drug targets. A series of C2-symmetric compounds encompassing the 1,2-dihydroxyethylene scaffold and a variety of elongated P1/P1‘ side chains were synthesized via microwave-assisted palladium-catalyzed coupling reactions. Binding affinity calculations with the linear interaction energy method and molecular dynamics simulations reproduced the experimental binding data obtained in a Plm II assay with very good accuracy. Bioactive conformations of the elongated P1/P1‘ chains were predicted and agreed essentially with a recent X-ray structure. The compounds exhibited picomolar to nanomolar inhibition constants for the plasmepsins and no measurable affinity to the human enzyme cathepsin D. Some of the compounds also demonstrated significant inhibition of parasite growth in cell culture. To the best of our knowledge, these plasmepsin inhibitors represent the most selective reported to date and constitute promising lead compounds for further optimization.Keywords
This publication has 32 references indexed in Scilit:
- High-Speed Optimization of Inhibitors of the Malarial Proteases Plasmepsin I and IIJournal of Combinatorial Chemistry, 2003
- Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human ErythrocytesJournal of Medicinal Chemistry, 2003
- Structures of Ser205 mutant plasmepsin II fromPlasmodium falciparumat 1.8 Å in complex with the inhibitors rs367 and rs370Acta Crystallographica Section D-Biological Crystallography, 2002
- Identification and Characterization of Allophenylnorstatine-Based Inhibitors of Plasmepsin II, an Antimalarial TargetBiochemistry, 2002
- Four plasmepsins are active in thePlasmodium falciparumfood vacuole, including a protease with an active-site histidineProceedings of the National Academy of Sciences, 2002
- New Class of Small Nonpeptidyl Compounds Blocks Plasmodium falciparum Development In Vitro by Inhibiting PlasmepsinsAntimicrobial Agents and Chemotherapy, 2001
- Target-Based Drug Discovery for Malaria, Leishmaniasis, and TrypanosomiasisCurrent Medicinal Chemistry, 2000
- Potent, Low-Molecular-Weight Non-Peptide Inhibitors of Malarial Aspartyl Protease Plasmepsin IIJournal of Medicinal Chemistry, 1999
- HEMOGLOBIN METABOLISM IN THE MALARIA PARASITEPLASMODIUM FALCIPARUMAnnual Review of Microbiology, 1997
- Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.Proceedings of the National Academy of Sciences, 1996